A group of 14 law firms representing nearly 20,000 plaintiffs is seeking to intervene in Bayer’s proposed class-action settlement of Roundup litigation, citing concerns that the deal will not be fair to cancer sufferers.
The group filed both a motion to intervene and a motion for an extension of time for court preliminary approval of the deal in St Louis city circuit court in Missouri late on 24 February.
The law firms say the deal appears “unprecedented” and raises multiple “red flags”.
“It is hard to escape the impression that the proposed settlement would give Monsanto everything it desires – a near-complete release of liability for Monsanto and its parent company, Bayer AG – while giving inadequate consideration to many putative class members, who would surrender their substantive rights in exchange for settlement offers that may never result in payment,” the law firms state in their motion.
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
